- Home
- » e-Newsletters
FDA approves new smallpox vaccine
Infection Control Monitor, September 7, 2007
The U.S. Food and Drug Administration (FDA) approved a second-generation smallpox vaccine on September 1 that could be used as protection against bioterrorist attacks.
The vaccine, called ACAM2000, is made by the British biotechnology company Acambis plc and is stockpiled by the U.S. government. The vaccine is "intended for the inoculation of people at high risk of exposure to smallpox and could be used to protect individuals and populations during a bioterrorist attack," the FDA said in a news release.
The FDA says the vaccine could be made quickly if smallpox, a highly contagious disease that is virtually eradicated, were to reappear, the Associated Press reported.
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Q/A: Coding for telescopic intraocular lens
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched